OBI Portfolio Company Mobio Interactive Advances Digital Therapeutics for Youth Concussion Recovery
19 mai 2026
A new milestone in pediatric concussion care has emerged from a collaboration between Ontario Brain Institute (OBI) portfolio company Mobio Interactive and OBI's concussion research program, TRANSCENDENT, bringing the promise of smartphone-delivered mental health support for adolescents one step closer to reality.
The collaboration recently yielded published findings from a randomized controlled trial (RCT) examining the feasibility of a digital therapeutic mindfulness-based intervention (DTx-MBI) for adolescents recovering from concussion. The results, published in JMIR Rehabilitation and Assistive Technologies, demonstrate strong recruitment, retention, and participant credibility outcomes, confirming that a larger, definitive trial is both achievable and warranted.
Addressing a Gap in Pediatric Concussion Care
While most young people recover from concussion within a few weeks, approximately one-third experience persisting symptoms that disrupt daily life, school, and well-being. Mental health history, psychological distress, and coping style are among the strongest predictors of prolonged recovery, yet accessible psychological interventions for this population have remained largely absent from the care toolkit.
Smartphone-delivered mindfulness-based interventions offer a promising path forward. By targeting modifiable psychological risk factors through a digital platform, this approach can help adolescents better regulate their emotions and support neurophysiological recovery, reducing overall symptom burden. Notably, this trial is the first of its kind: no digital therapeutic RCT had previously been conducted in adolescents experiencing concussion.
From Portfolio Company to Clinical Evidence
The collaboration between Mobio Interactive and TRANSCENDENT exemplifies the industry-research partnerships that OBI fosters through its integrated discovery model. Mobio Interactive contributed its smartphone-delivered mindfulness application, while TRANSCENDENT brought together the clinical research infrastructure and concussion expertise needed to rigorously evaluate it across its program sites, including CHEO Research Institute.
The feasibility trial's positive outcomes now lay the groundwork for a larger RCT with modifications to further enhance participant adherence. If successful, the DTx-MBI could become a cost-effective adjunct to standard pediatric concussion care, extending access to evidence-based psychological support well beyond the clinic.